Kevin R. Loughlin, MD, MBA

home / authors / kevin-r-loughlin-md-mba

Articles

Surgical Challenges and Opportunities in Treating Penile Cancer

Surgical Challenges and Opportunities in Treating Penile Cancer

Kevin R. Loughlin, MD, MBA
August 3rd 2018

Kevin R. Loughlin, MD, MBA, discusses the diagnosis, staging, and management of penile cancer.

Read More

Life After Obamacare

Life After Obamacare

Kevin R. Loughlin, MD, MBA
September 8th 2014

If one had to choose a single word to describe the future of Obamacare, it would probably be "uncertain."

Read More

The Burden Of Entitlement Programs on the Future Funding of Health Care

The Burden Of Entitlement Programs on the Future Funding of Health Care

Kevin R. Loughlin, MD, MBA
June 5th 2014

Our country is facing present and future fiscal challenges that have never been encountered before in our nation's history. Our major entitlement programs are not new.

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data